Plasmacytosis in acute myeloid leukemia: Two cases of plasmacytosis and increased IL-6 production in the AML blast cells

Annals of Hematology

Volumn 76, Issue 6, 1998, Pages 273-277

  Wulf, G G ^a   Jahns Streubel, G ^a   Hemmerlein, B ^a   Bonnekessen, K ^a   Wormann B ^a   Hiddemann, W ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Acute myeloid leukemia; IL 6; Plasmacytosis

Indexed keywords

CISPLATIN; CYTARABINE; ETOPOSIDE; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 6; MELPHALAN; PREDNISOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BLAST CELL; BONE MARROW CELL; CASE REPORT; CELL CULTURE; CYTOGENETICS; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOGENETICS; MALE; PLASMA CELL; PLASMACYTOSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ACUTE DISEASE; AGED; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; INTERLEUKIN-6; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MALE; MIDDLE AGED; PLASMACYTOMA;

EID: 0031857088     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050401     Document Type: Article

References (26)

1. Baddoura FK, Hanson C, Chan WC (1992) Plasmacytoid monocyte proliferation associated with myeloproliferative disorders. Cancer 69:1457-1467
2. Bergamaschi G, Cazzola M, Rosti v, Carl-Stell C, Santini V, Ponchio L, Peverali FA, Valle GD, Ferrini PR, Ascari E (1991) Tumor necrosis factor a modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia. Leukemia 5:886-891
3. Gavarotti P, Boccadoro M, Redolia V, Golizio F, Pileri A (1985) Reactive plasmacytosis. Case report and review of the literature. Acta Hematol 73:108-110
4. Hilbert DM, Kopf M, Mock BA, Kohler G, Rudekoff S (1995) Interleukin-6 is essential for in vitro development of B lineage neoplasms. J Exp Med 182:243-248
5. Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, Nakajima K, Pyun KH, Kishimoto T (1985) Purification to homogeneity and characterization of human B cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA 82:5490-5494
6. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashimura S, Nakajima K, Koyama K, Iwamatu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T, Kishimoto T (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B-lymphocytes to produce immunoglobulin. Nature 324:73-76
7. Hoang T, Haman A, Gonclaves O, Wong GG, Clark SC (1988) Interleukin-6 enhances growth factor-dependent proliferation of blast cells of acute myeloblastic leukemia. Blood 72:823-826
8. Hyun BH, Kwa D, Gabaldon H, Ashton JK (1975) Reactive plasmacytic lesions of the bone marrow. Am J Clin Pathol 65:921-928
9. Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M (1987) Interleukin-6 enhancement of interleukin-3-dependent proliferation of multipotential hematopoietic progenitors. Proc Natl Acad Sci USA 84:9035-9039
10. Ishibashi T, Kimura H, Uchida T, Kariyone S, Friese P, Burstein SA (1989) Interleukin-6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci USA 86:5953-5957
11. Jahns-Streubel G, Haase D, Schoch C, Wörmann B, Büchner T, Fonatsch C, Hiddemann W (1996) Cytogenetic subgroups of acute myeloid leukemia (AML) differ significantly in proliferative activity, cytokine production and sensitivity to GM-CSF stimulation. Blood 88 [Suppl 1]: 560a (abstract)
12. Kamano MM, Mihara K, Huang N, Tsujimoto T, Kuramoto A (1995) Differentiation of early plasma cells on bone marrow stroma cells requires interleukin-6 for escaping from apoptosis. Blood 85:487-494
13. Kyoda K, Nakamura S, Matano S, Ohtake S, Matsuda T (1997) Prognostic significance of immunoglobulin heavy chain gene rearrangement in patients with acute myelogeneous leukemia. Leukemia 11:803-806
14. Lichtenstein A, Tu Y, Fady C, Vescio R, Berenson J (1995) Interleukin-6 inhibits apoptosis of malignant plasma cells. Cell Immunol 162:248-255
15. Linke B, Bolz I, Pott C, Hiddemann W, Kneba M (1995) Use of U1Tma DNA polymerase improves the PCR detection of rearranged immunoglobulin heavy chain CDR3 junctions. Leukemia 9:2133
16. Linke B, Bolz B, Fayyazi A, von Hofen M, Pott Ch, Bertram J, Hiddemann W, Kneba M (1997) Automated high-resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes. Leukemia 11:1055-1062
17. Liu CT, Dahlke MB (1967) Bone marrow findings of reactive plasmacytosis. Am J Clin Pathol 48:546-551
18. Lu ZY, Zhang XG, Rodriguez C (1995) Interleukin-10 is a proliferative but not differentiation factor for human myeloma cells. Blood 85:2521-2525
19. Oster W, Cicco NA, Klein H, Hirano T, Kishimoto T, Lindemann A, Mertelsmann RH, Herrmann F (1989) Participation of interleukin-6, tumour necrosis factor-a and interleukin 1-ß secreted by acute myelogeneous leukemia blasts in autocrine and paracrine leukemia growth control. J Clin Invest 84:451-457
20. Parreira L, Carvalho C, Moura H, Melo A, Santos P, Guimaraes JE, Parreira A (1992) Configuration of immunoglobulin and T cell receptor ß and g genes in acute myeloid leukemia: pitfalls in the analysis of 40 cases. J Clin Pathol 45:193-200
21. Rosenthal NS, Farhi DC (1994) Reactive plasmacytosis and lymphocytosis in acute myeloid leukemia. Hematol Pathol 8:43-51
22. Selvaney P, Block M, Narni R (1988) Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma. Blood 71:30-36
23. Sivasankaran S, Das KV, Thomas M, Pillai R, Balaram P, Augustin J, Aleykully MA (1989) Adrenal carcinoma with reactive plasmacytosis. J Assoc Physicians India 37:237-239
24. Taga T, Kawanishi K, Hardy RR, Hirano T, Kishimoto T (1987) Receptors for B cell stimulatory factor 2 (BSF-2): quantification, specificity. distribution and regulation of expression. J Exp Med 167:332-344
25. Terashini T, Hirano T, Arima N, Onoue K (1982) Human helper T cell factor(s). II. Induction of IgG production in B lymphoblastoid cell lines and identification of T cell-replacing factor (TRF)-like factor(s). J Immunol 128:1903-1908
26. Zhu Y-M., Bradbury DA, Keith FJ, Russell N (1994) Absence of retinoblastoma protein expression results in autocrine production of interleukin-6 and promotes the autonomous growth of acute myeloid leukemia blast cells. Leukemia 8:1982-1988